Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCS12 versus Yasmin for contraceptive satisfaction in young women
2010-020181-21Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in contraception comparing LCS12 intrauterine system with Yasmin combined oral contraceptive (2 arms). Primary endpoint: Overall satisfaction rate. Started Oct 2010; status: completed.
02
Drugs
LoviOnedrospirenone
03
Conditions
contraception
Beyond the preview
Go deeper on 2010-020181-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-020181-21.